April 9, 2024 10:58 AM EDT
News Briefing

Acrivon draws in $130M; Vin­cerx Phar­ma's Ph1 metasta­t­ic tu­mor da­ta

ENDPOINTS

Acrivon rais­es $130M PIPE: The pre­ci­sion on­col­o­gy biotech brought in the mon­ey from RA Cap­i­tal, Per­cep­tive Ad­vi­sors and oth­er in­vestors. Its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi faces $250M charge af­ter J&J-part­nered vac­cine flunks late-stage test

Kennedy is con­firmed to lead HHS, putting an­ti-vac­cine ad­vo­cate and drug in­dus­try skep­tic atop US health pro­grams

Af­ter help­ing build Al­phaFold, a 34-year-old first-time CEO launch­es his own AI biotech with $50M

Newleos, a new biotech with $93.5M, re­pur­pos­es Roche's ex­per­i­men­tal CNS drugs

Neumo­ra shakes up C-suite a month af­ter de­pres­sion drug fails first Phase 3 tri­al

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times